InvestorsHub Logo
Followers 2
Posts 104
Boards Moderated 0
Alias Born 12/23/2017

Re: rwwest post# 27470

Friday, 07/19/2019 10:21:40 AM

Friday, July 19, 2019 10:21:40 AM

Post# of 34626
Totally agree. To say "it is encouraging" is undervalued for this exciting result in PC!

The ARM A is very meaningful because those are patients with advanced and metastatic diseases. The survival rate in this group is very very dismal 3% survival rate and with a median survival of 5-10 months. Now we have 5/9 stabilized disease including one with complete response. That is very promising, not just encouraging.

In ARM B, these are patients refractory to current chemotherapy. Now 3/3 patients are stable after MUltiTAA infusions. That is very promising too.

What an unexpected buying opportunity!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News